Basilea Pharmaceutica AG
BPMUF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $128 | $121 | $63 | $60 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $56 | $57 | $28 | $28 |
| Inventory | $23 | $32 | $31 | $26 |
| Other Curr. Assets | $10 | $12 | $33 | $38 |
| Total Curr. Assets | $217 | $221 | $155 | $152 |
| Property Plant & Equip (Net) | $18 | $19 | $19 | $21 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $1 |
| Long-Term Investments | $0 | $0 | -$0 | $0 |
| Tax Assets | $13 | $17 | $13 | $0 |
| Other NC Assets | $0 | $0 | $0 | -$0 |
| Total NC Assets | $31 | $37 | $34 | $21 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $249 | $258 | $189 | $173 |
| Liabilities | – | – | – | – |
| Payables | $10 | $11 | $11 | $6 |
| Short-Term Debt | $2 | $2 | $2 | $18 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $17 |
| Other Curr. Liab. | $22 | $32 | $24 | $7 |
| Total Curr. Liab. | $34 | $46 | $38 | $48 |
| LT Debt | $95 | $110 | $110 | $111 |
| Deferred Rev, NC | $10 | $11 | $9 | $9 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $10 | $15 | $15 |
| Total NC Liab. | $111 | $131 | $134 | $136 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $15 | $16 | $17 | $18 |
| Total Liabilities | $146 | $177 | $172 | $183 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $9 | $10 |
| Common Stock | $13 | $13 | $13 | $13 |
| Retained Earnings | -$907 | -$923 | -$980 | -$1,001 |
| AOCI | -$2 | -$5 | -$9 | -$10 |
| Other Equity | $999 | $996 | $984 | $978 |
| Total Equity | $103 | $81 | $17 | -$10 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $249 | $258 | $189 | $173 |
| Net Debt | -$32 | -$9 | $49 | $69 |